McFarlane and National Disability Insurance Agency [2018] AATA 4727 (17 December 2018)
Division:NATIONAL DISABILITY INSURANCE SCHEME DIVISION
File Number: 2017/3849
Re:Jason McFarlane
APPLICANT
AndNational Disability Insurance Agency
RESPONDENT
DECISION
Tribunal:Dr L Bygrave, Member
Date:17 December 2018
Place:Sydney
The decision under review is affirmed.
..........................[sgd].........................................
Dr L Bygrave, Member
CATCHWORDS
NATIONAL DISABILITY INSURANCE SCHEME – access – whether applicant meets access criteria – fibromyalgia – chronic pain syndrome – whether applicant meets the disability requirements – whether applicant meets the early intervention requirements –meaning of disability – whether applicant’s impairments permanent – whether impairments result in substantially reduced functional capacity in one or more activities – whether applicant’s impairments affect capacity for social or economic participation – whether applicant likely to require support under the NDIS for his lifetime – benefit of early intervention support – whether support most appropriately funded or provided through NDIS – decision under review affirmed
LEGISLATION
National Disability Insurance Scheme Act 2013 (Cth) ss 3, 4, 21, 22, 23, 24, 25, 103, 209
National Disability Insurance Scheme (Becoming a Participant) Rules 2016 (Cth)
CASES
Mulligan v National Disability Insurance Agency [2015] FCA 544
Re Drake and Minister for Immigration and Ethnic Affairs (No 2) [1979] AATA 179; (1979) 2 ALD 634
SECONDARY MATERIALS
National Disability Insurance Agency, Operational Guideline – Access to the NDIS
REASONS FOR DECISION
Dr L Bygrave, Member
17 December 2018
INTRODUCTION
Mr Jason McFarlane applied to become a participant in the National Disability Insurance Scheme (the NDIS) on 6 December 2016. In the NDIS access request form, Dr Samuel Nosike (general practitioner) listed Mr McFarlane’s disabilities as:
1. fibromyalgia
2. chronic pain syndrome
3. lateral epicondylitis (bilateral arms)
4. De Quervains tendonitis
5. right wrist synovitis[1]
[1] Exhibit T-T11, page 28.
On 3 January 2017, a delegate of the Chief Executive Officer (CEO) of the National Disability Insurance Agency (the NDIA) determined that Mr McFarlane does not meet the access criteria specified in sections 21–25 of the National Disability Insurance Scheme Act 2013 (Cth) (the NDIS Act).
Mr McFarlane requested an internal review and, on 21 June 2017, the NDIA affirmed the decision (the internal review decision).
On 2 July 2017, Mr McFarlane made an application for review of the internal review decision to the NDIS Division of the Administrative Appeals Tribunal (the Tribunal). The Tribunal has jurisdiction to review the internal review decision pursuant to section 103 of the NDIS Act.
The Tribunal initially heard the matter in Newcastle on 21 February 2018 so Mr McFarlane could attend the hearing and provide evidence in person. The Tribunal then adjourned the hearing to allow Mr McFarlane to seek further medical evidence. The Tribunal resumed the hearing in Sydney on 8 and 9 November 2018; Mr McFarlane attended these hearing days by telephone with the support of his disability advocate. Mr McFarlane had legal representation throughout the hearing process.
RELEVANT LEGISLATION
The Parliament of Australia expressly provided objects and principles in the NDIS Act to give…
Keep reading for free
Create a free CaseChat account to read McFarlane and National Disability Insurance Agency and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2018] AATA 4727
- Decision Date
CaseChat Overview and Summary
The primary legal issues before the Tribunal were whether Mr. McFarlane's fibromyalgia and chronic pain syndrome qualified as "disability" under the NDIS Act, specifically whether these conditions constituted impairments that resulted in a substantially reduced functional capacity in one or more activities, affected his capacity for social or economic participation, and were likely to require NDIS support for his lifetime. Additionally, the Tribunal had to consider whether the benefit of early intervention support was most appropriately funded or provided through the NDIS.
The Tribunal considered evidence from Mr. McFarlane, his treating general practitioner, an occupational therapist, and expert medical opinions. The NDIA argued that the experience of pain from fibromyalgia did not constitute a loss of, or damage to, a physical, sensory, or mental function, and therefore was not an impairment under the Act. Conversely, Mr. McFarlane's representatives contended that his physical impairments caused severe pain, substantially restricting his ability to function. The Tribunal noted that the NDIS definition of disability focuses on the reduction or loss of an ability to perform an activity resulting from an impairment, and that this definition targets individuals with significant functional capacity limitations.
Ultimately, the Tribunal found that Mr. McFarlane did not meet the access criteria under either section 24 (disability requirements) or section 25 (early intervention requirements) of the NDIS Act. Consequently, the Tribunal affirmed the NDIA's internal review decision.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
Professor Littlejohn disagreed with Professor Cameron’s view that a person with fibromyalgia would not require support for their lifetime. He described fibromyalgia as a ‘neurophysiological condition’ and explained that a percentage (a minority) of people with severe fibromyalgia are unlikely to have their impairments remedied by current evidence-based treatment and will require lifelong support, although this can only be decided once a person has attempted all treatment options.CONSIDERATION In his evidence to the Tribunal on 21 February 2018, Dr Nosike stated that Mr McFarlane’s conditions of lateral epicondylitis (bilateral arms), De Quervain’s tendonitis and right wrist synovitis can be excluded from his application for the NDIS in view of his diagnosis of fibromyalgia. Dr Nosike also accepted that it is difficult to distinguish between the aetiology of Mr McFarlane’s fibromyalgia, which is defined as a generalised pain condition, and his chronic pain syndrome. In view of Dr Nosike’s evidence, I only consider Mr McFarlane’s conditions of fibromyalgia and chronic pain syndrome in relation to the access requirements in sections 24 and 25 of the NDIS Act.The disability requirements Subsection 24(1) of the NDIS Act is satisfied if Mr McFarlane meets all five requirements specified in paragraphs 24(1)(a) to (e). I now consider each of these requirements.Does Mr McFarlane have a disability within the meaning of paragraph 24(1)(a)? Consistent with Mortimer J’s decision in Mulligan v National Disability Insurance Agency [2015] FCA 544 at [15] to [16], Chapter 8.1 of the Access Operational Guideline includes the following paragraphs:For the purposes of becoming a participant in the NDIS the focus of ‘disability’ is on the reduction or loss of an ability to perform an activity which results from an impairment.The term ‘impairment’ commonly refers to a loss of, or damage to, a physical, sensory or mental function.The narrower definition of ‘disability’ employed by the NDIS seeks to target those people with disability who have a significant impairment to their functional capacity. This functional definition of disability focuses on outcomes for people with disability that are in the most need (Explanatory Statement to the Becoming a Participant Rules). The NDIA contended that Mr McFarlane’s fibromyalgia and chronic pain syndrome are not ‘impairments’ within the meaning of the NDIS Act. Relying on Professor Cameron’s report, the NDIA submitted that fibromyalgia is not an impairment because the ‘experience of pain does not represent “a loss of, or damage to, a physical, sensory or mental function”’.[30] [30] Respondent’s Amended Statement of Position dated 24 August 2018, paragraph 4.10. The applicant’s legal representative submitted that Dr Nosike’s evidence shows that Mr McFarlane’s physical impairments cause ‘severe pain that hinders his movements at home and participation in society’ and he has a disability because ‘his physical impairments substantially restrict his ability to function’.[31][31] Applicant’s Amended Statement of Position filed on 10 August 2018, paragraph 15.